Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Ashfield launches new commercial model to improve ROI

Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, announced the launch of a pioneering new commercial model called The Ashfield Solution.

Read More »

Pacemakers, defibrillators are potentially hackable

Heart devices that use software or wireless communications may be vulnerable to hacker attacks that could cause life-threatening malfunctions, U.S. cardiologists say.

Read More »

Genes may not predict low-fat or low-carb diet success

People who try to avoid junk food may lose similar amounts of weight on a low-carb or low-fat diet even when their genetics suggest that one of these options should be better for them.

Read More »

PDL BioPharma Gives Up On Acquiring Neos

Nevada-based PDL BioPharma will no longer pursue a proposed acquisition of Neos Therapeutics. PDL made three failed attempts to acquire Texas-based Neos.

Read More »

AbbVie, Voyager Launch Alzheimer’s Partnership

Chicago-based AbbVie and Cambridge, Mass.-based Voyager Therapeutics inked a collaboration deal to develop treatments for Alzheimer’s disease and other neurodegenerative diseases.

Read More »

U.S. to extend skimpy health insurance outside of Obamacare

The U.S. government proposed extending the availability of skimpy health insurance plans to millions of Americans in another Trump administration move aimed at undercutting the requirements of the Affordable Care Act, often called Obamacare.

Read More »

Aimmune’s peanut allergy drug meets main goal

U.S. drug developer Aimmune Therapeutics Inc.’s peanut allergy drug met the main goal of an eagerly awaited late-stage study.

Read More »

Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders

Wave Life Sciences Ltd. announced the formation of a global strategic collaboration with Takeda Pharmaceutical Company Ltd. to discover, develop and commercialize nucleic acid therapies for disorders of the central nervous system.

Read More »

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases

Shire, Microsoft and EURORDIS-Rare Diseases Europe announced a strategic alliance to address the diagnostic challenge for patients living with a rare disease.

Read More »

Eli Lilly and Hanmi Shutter a Failed Phase II RA Trial

Eli Lilly and its Korean collaborative partner Hanmi Pharmaceutical stopped a Phase II trial on an experimental rheumatoid arthritis treatment after less-than-stellar interim results were examined.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom